Pharmaceuticals

Accelerate pharmaceutical development with Bruker Raman imaging microscopy. Map active ingredients, detect polymorphs, and monitor formulation uniformity to ensure drug safety and efficacy with precise chemical insight.

Distinguishing polymorphs of active pharmaceutical ingredients

Polymorphism in pharmacology refers to varied crystal forms of a drug, impacting therapeutic effects and absorption rates due to differing physical and chemical properties. Polymorph stability also affects medication shelf life and storage. Analytical techniques like X-ray diffraction and Raman spectroscopy identify crystal forms, with Raman offering advantages including non-destructiveness, surface analysis, ease of use, and minimal sample preparation. RAMANtouch determined the crystal polymorph distribution of mefenamic acid, a painkiller with anti inflammatory and anti pyretic effects.

The figure shows the distribution of a mixture of these two crystal forms, imaged using fast and high-resolution Raman imaging. The red color represents the distribution of crystal Form I, while the yellow-green color represents the distribution of crystal form II. The spectra of the two forms show clear differences.

Raman imaging was conducted across an area of 0.5 mm square with a spatial resolution of approximately 700 nm and a measurement time of ~20 minutes. This allows for the quick generation of a detailed distribution map showing the various polymorphs.